P. Gabriel Steg MD, FESC, FACC

Dr. Steg is the Chief of the Department of Cardiology at Hôpital Bichat in Paris, France. He is the Vice President (in charge of research) of the board of the Assistance Publique-Hôpitaux de Paris network since 2018. Since 1994, Dr. Steg has been a Professor of Cardiology at Université Paris – Diderot (now Université Paris-Cité). He has been a Senior member, Innovation Professorship, of the Institut Universitaire de France since 2022. Dr. Steg is also the Director of the “Clinical Research in Atherothrombosis” Research Team 5, INSERM Unit UMR 1148/LVTS, Paris and Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) RHU research consortium 2017-2023. Since 2013, Dr. Steg has acted as Chair of the FACT (French Alliance for Cardiovascular clinical Trials) academic research network and Chairman of the French National University Council (Conseil National des Universités) for Cardiology, since 2016.

Dr. Steg received the silver medal of the European Society of Cardiology in 2011, the Joseph A Vita Award from the American Heart Association in 2019, the Grand Prix Claude Bernard de la Ville de Paris in 2019 and the Prix Simone and Cino Del Duca de Cardiologie in 2022.

Dr. Steg has accumulated experience as a clinical trialist in the field of coronary artery disease, diabetes and antithrombotics. He is currently leading several large phase III clinical trials or international registries.

Dr. Steg has authored > 1900 articles in peer-reviewed international journals. His H-Index is 149 (Web of Science) and he has > 130 000 citations. He has been a Thomson Reuters/Clarivate Analytics ”highly cited researcher” in Clinical Medicine every year since 2014. He is Senior Associate Editor for Circulation.